These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6369979)

  • 1. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
    Henry SA
    Am J Med; 1984 Apr; 76(4):645-51. PubMed ID: 6369979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
    Zinner SH
    Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia.
    Wade JC; Schimpff SC; Hargadon MT; Fortner CL; Young VM; Wiernik PH
    N Engl J Med; 1981 Apr; 304(18):1057-62. PubMed ID: 6782486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
    Malarme M; Meunier-Carpentier F; Klastersky J
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1315-22. PubMed ID: 7040086
    [No Abstract]   [Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
    Gurwith M; Truog K; Hinthorn D; Liu C
    Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
    Bow EJ; Rayner E; Scott BA; Louie TJ
    Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial.
    Pizzo PA; Robichaud KJ; Edwards BK; Schumaker C; Kramer BS; Johnson A
    J Pediatr; 1983 Jan; 102(1):125-33. PubMed ID: 6336781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin for infection prevention in patients with acute leukemia.
    Rozenberg-Arska M; Dekker AW
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S45-7. PubMed ID: 3325929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria.
    Rozenberg-Arska M; Dekker AW; Verhoef J
    Infection; 1983; 11(3):167-9. PubMed ID: 6604030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia.
    Starke ID; Donnelly P; Catovsky D; Darrell J; Johnson SA; Goldman JM; Galton DA
    Lancet; 1982 Jan; 1(8262):5-6. PubMed ID: 6119443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
    J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic co-trimoxazole and lactobacilli preparation in neutropenic patients.
    Ekert H; Jurk IH; Waters KD; Tiedemann K
    Med Pediatr Oncol; 1980; 8(1):47-51. PubMed ID: 6969348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients.
    Bow EJ; Louie TJ; Riben PD; McNaughton RD; Harding GK; Ronald AR
    Am J Med; 1984 Feb; 76(2):223-33. PubMed ID: 6364804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.
    Dekker AW; Rozenberg-Arska M; Sixma JJ; Verhoef J
    Ann Intern Med; 1981 Nov; 95(5):555-9. PubMed ID: 6794406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
    Wade JC; de Jongh CA; Newman KA; Crowley J; Wiernik PH; Schimpff SC
    J Infect Dis; 1983 Apr; 147(4):624-34. PubMed ID: 6842003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients.
    Klastersky J
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):201S-207S. PubMed ID: 2686921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients. A prospective, randomized, double-blind study.
    Stuart RK; Braine HG; Lietman PS; Saral R; Fuller DJ
    Am J Med; 1980 Jun; 68(6):876-85. PubMed ID: 6992570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprophylaxis of gram-negative infections in neutropenic patients.
    Klastersky J
    Eur Urol; 1990; 17 Suppl 1():40-5. PubMed ID: 2162299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Co-trimoxazole chemoprophylaxis in immunocompromised patients: analysis of the literature].
    Gava R; Carli M
    G Clin Med; 1989 Jan; 70(1):37-9, 42-6. PubMed ID: 2668092
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing infection in neutropenic cancer patients.
    Beutler SM; Barth NM; Bayer AS
    West J Med; 1983 May; 138(5):690-8. PubMed ID: 6880186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.